Key Program of the National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81830008, 81630006]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81300410, 81873452, 81600120, 81670152, 81873444, 81570196]; Milstein Medical Asian American Partnership Foundation (2018 MMAAP Foundation Hematology Fellowship Award); Applied Basic Research Project of Wuhan City [2017060201010156]
第一作者单位：[1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Hematol, Wuhan 430030, Hubei, Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Wang D.,Zeng C.,Xu B.,et al.Anti-CD30 chimeric antigen receptor T cell therapy for relapsed/refractory CD30(+) lymphoma patients[J].BLOOD CANCER JOURNAL.2020,10(1):doi:10.1038/s41408-020-0274-9.
APA：
Wang, D.,Zeng, C.,Xu, B.,Xu, J. -H.,Wang, J....&Zhou, J. -F..(2020).Anti-CD30 chimeric antigen receptor T cell therapy for relapsed/refractory CD30(+) lymphoma patients.BLOOD CANCER JOURNAL,10,(1)
MLA：
Wang, D.,et al."Anti-CD30 chimeric antigen receptor T cell therapy for relapsed/refractory CD30(+) lymphoma patients".BLOOD CANCER JOURNAL 10..1(2020)
医学